OTC · Medical - Devices

LifeTech Scientific Corporation (LFTSF) Stock

$0.23 +0.00% OTC: LFTSF Healthcare

LifeTech Scientific Corporation, established in 1999 and headquartered in Shenzhen, People's Republic of China, operates as an investment holding company. Its primary focus is the development, manufacturing, and commercialization of state-of-the-art interventional medical devices specifically designed to address cardiovascular and peripheral vascular ailments.

Valuation

MetricValue
Price$0.23
Market Cap$1.03B
P/E Ratio38.30
P/B Ratio1.68
P/S Ratio4.06
EPS (TTM)$0.01
52-Week High$0.23
52-Week Low$0.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.06%
ROA2.95%
ROCE5.23%
Gross Margin74.40%
Operating Margin13.48%
Net Margin10.79%
Debt/Equity0.00
Current Ratio1.57

Annual Financials (USD)

Metric20212022202320242025
Revenue$925.0M$1.1B$1.3B$1.3B$1.4B
Operating Profit$329.0M$376.0M$383.0M$186.0M$176.0M
Net Profit$292.0M$325.0M$263.0M$222.0M$148.0M
EPS$0.06$0.07$0.06$0.05$0.03
Op Margin35.5%34.3%30.3%14.3%12.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$3.2B$3.7B$4.7B$4.9B$5.0B
Total Liabilities$654.0M$769.0M$1.4B$1.4B$1.5B
Cash$1.1B$834.0M$979.0M$666.0M$719.0M
Borrowings$16.0M$10.0M$9.0M$5.0M$8.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$489.0M$388.0M$418.0M$321.0M$549.0M
Investing Cash Flow$-430.0M$-794.0M$-747.0M$-801.0M$-278.0M
Financing Cash Flow$89.0M$66.0M$218.0M$36.0M$19.0M
Net Cash Flow$148.0M$-285.0M$146.0M$-314.0M$54.0M
Free Cash Flow$146.0M$53.0M$125.0M$38.0M$399.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.13
EV / EBITDA16.45
FCF Yield9.16%
Quick Ratio1.27
Interest Coverage1707.73
Return 1Y0.00%
Return 3Y-31.32%
Return 5Y—

Ownership

Insiders Held22.45%
Institutions Held7.10%
Institutions Float Held9.16%
Institutional HolderSharesReport Date
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund52,788,6192026-04-30
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard Emerging Markets Stock Index Fd51,039,0592026-04-30
iShares, Inc.-iShares Core MSCI Emerging Markets ETF41,652,0002026-06-30
DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT.18,192,0002026-04-30
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap 13,742,0582026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARRJFArjo AB (publ) $2.74 +0.00% 19.10 $746.29M 3.65%
ELEAFEL.En. S.p.A. $18.50 +0.00% 14.80 $1.48B 1.57%
EXETFExtendicare Inc. $25.94 -5.02% 26.35 $2.46B 1.46%
NNCSFNanosonics Limited $2.07 -5.48% 46.97 $618.75M 0.00%
PHCIPanamera Holdings Corporation $2.50 +0.00% -1.20 $184.72M 0.00%

About LifeTech Scientific Corporation

LifeTech Scientific Corporation, established in 1999 and headquartered in Shenzhen, People's Republic of China, operates as an investment holding company. Its primary focus is the development, manufacturing, and commercialization of state-of-the-art interventional medical devices specifically designed to address cardiovascular and peripheral vascular ailments. The company structures its operations across three distinct segments: Structural Heart Diseases, Peripheral Vascular Diseases, and Cardiac Pacing and Electrophysiology. LifeTech's comprehensive product lineup features a diverse array of critical medical solutions. These include devices such as the LAmbre systems for closing left atrial appendages, a range of CeraFlex, Cera, Heart, and Konara-MF occluders used for ventricular septal defects, and Ankura stent graft systems for both thoracic and abdominal aortic aneurysms. The portfolio also encompasses essential delivery systems like Fustar steerable and SteerEase introducers, Aegisy vena cava filters, Cera vascular plug systems, AcuMark sizing balloons, LawMax dilators, SeQure snare systems, and pacemakers. Beyond its core medical device activities, the corporation engages in biomedical research and development, manufactures and trades hemp-derived materials, provides staff training and internal management services, offers investor information consulting, and delivers various technical and consulting services. LifeTech Scientific boasts a substantial international presence, conducting operations throughout Mainland China, India, other Asian countries, Europe, South America, Africa, and numerous other global markets.

LifeTech Scientific Corporation is headquartered in CN.

LifeTech Scientific Corporation (LFTSF) stock trades at $0.23 with a market capitalization of $1.03B. The stock is valued at a price-to-earnings (P/E) ratio of 38.30, price-to-book of 1.68, price-to-sales of 4.06. Over the past 52 weeks the stock has ranged between $0.23 and $0.23, and currently trades at its 52-week high.

On profitability, LifeTech Scientific Corporation generates a return on equity (ROE) of 4.06%, return on capital employed of 5.23%, an operating margin of 13.48%, a net profit margin of 10.79%.

Official website: www.lifetechmed.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides